Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-09

Clinical Trial Update: Reduced PCV Dosing Schedules in South African Infants [Phase 3]

View source ↗

Summary

A Phase 3 trial updating reduced PCV dosing schedules in South African infants has completed, evaluating pneumonia and meningitis outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Witwatersrand, South Africa | Conditions: Pneumonia, Meningitis | Phase 3 | Status: COMPLETED